Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.

被引：0
|
作者：
Hammer, Liat
Rebernick, Ryan
McFarlane, Matthew
Westbrook, Thomas
Hazime, Munna
Hammoud, Tanya
Chiu, Pin-en
Xavier, Owens
Wu, Yi-Mi
Robinson, Dan R.
Spratt, Daniel Eidelberg
Alva, Ajjai Shivaram
Jackson, William C.
Reichert, Zachery R.
Alumkal, Joshi J.
Chinnaiyan, Arul
Cieslik, Marcin
Dess, Robert Timothy
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Case Western Reserve Univ, Univ Hosp Cleveland, Med Ctr, Cleveland, OH USA
[3] Univ Michigan, Div Hematol & Oncol, Dept Internal Med, Ann Arbor, MI USA
[4] Univ Michigan, Canc Ctr, Ann Arbor, MI USA
[5] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[6] Univ Michigan, Med Ctr, Ann Arbor, MI USA
[7] Michigan Med, Ann Arbor, MI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
263
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Dynamic Mutation Profiles of SCLC Transformation in NSCLC Patients Harboring Concurrent EGFR/TP53/RB1 Mutations
    Huang, J.
    Huang, W.
    Wang, Q.
    Zhang, C.
    Ni, S.
    Sun, D.
    Zhou, Y.
    Hou, T.
    Sun, W.
    Chen, Z.
    Wu, Y. -L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S48 - S48
  • [42] Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Zhang, Wensheng
    Dong, Yan
    Sartor, Oliver
    Zhang, Kun
    CANCER INFORMATICS, 2022, 21
  • [43] Deciphering the Increased Prevalence of TP53 Mutations in Metastatic Prostate Cancer
    Zhang, Wensheng
    Dong, Yan
    Sartor, Oliver
    Zhang, Kun
    CANCER INFORMATICS, 2022, 21
  • [44] Study of polymorphisms in the TP53 and RB1 genes in children with retinoblastoma in northern Mexico
    Anaya-Pava, Edwin J.
    Nares-Cisneros, Jesus
    Cardenas-Hernandez, Ruben I.
    Jaramillo-Rodriguez, Yolanda
    Zambrano-Galvan, Graciela
    MOLECULAR VISION, 2017, 23 : 20 - 25
  • [45] Genetic Characteristics of EGFR Concurrent Variants with RB1 and TP53 in NCSLC Patients
    Chen, H.
    Yuan, S.
    Chen, L.
    Shi, X.
    Wang, L.
    Dong, X.
    Wang, M.
    Wang, A.
    Liu, W.
    Cui, Z.
    Chen, C.
    Mei, L.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S587 - S588
  • [46] TP53 Mutations in Advanced Colorectal Cancer: The Dark Side of the Moon
    Pietrantonio, Filippo
    Biondani, Pamela
    Perrone, Federica
    Di Bartolomeo, Maria
    Pacifici, Monica
    Milione, Massimo
    Melotti, Flavia
    Maggi, Claudia
    Montennurro, Gabriella
    Bossi, Ilaria
    Mariani, Luigi
    de Braud, Filippo
    ONCOLOGY, 2014, 86 (5-6) : 289 - 294
  • [47] A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
    Kobayashi, Hiroaki
    Kosaka, Takeo
    Nakamura, Kohei
    Shojo, Kazunori
    Hongo, Hiroshi
    Mikami, Shuji
    Nishihara, Hiroshi
    Oya, Mototsugu
    BMC MEDICAL GENOMICS, 2021, 14 (01)
  • [48] A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations
    Hiroaki Kobayashi
    Takeo Kosaka
    Kohei Nakamura
    Kazunori Shojo
    Hiroshi Hongo
    Shuji Mikami
    Hiroshi Nishihara
    Mototsugu Oya
    BMC Medical Genomics, 14
  • [49] RB1 and TP53 co-mutations correlate strongly with genomic biomarkers of response to immunity checkpoint inhibitors in urothelial bladder cancer
    Gonzalez Manzano, Ramon
    Catalan-Latorre, Ana
    Brugarolas, Antonio
    BMC CANCER, 2021, 21 (01)
  • [50] Characteristics and survival of patients with advanced cancer and TP53 mutations in phase I clinical trials
    Said, Rabih
    Ye, Yang
    Hong, David S.
    Janku, Filip
    Fu, Siqing
    Naing, Aung
    Wheler, Jennifer J.
    Kurzrock, Razelle
    Thomas, Christoforos
    Palmer, Gary A.
    Hess, Kenneth R.
    Wolff, Robert A.
    Tsimberidou, Apostolia Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345